Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
Background: Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective: Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method: Unicentric observational retrospective study including adul...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-02-01
|
| Serier: | Actas Dermo-Sifiliográficas |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S0001731023008189 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
